NOI to Sole Source PhysioMimix Organ-on-a-Chip systems
Closed Special Notice Posted
- Solicitation number
- HT942626QE019
- Agency
- Not on record
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Frederick, Maryland 21702, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency Contracting Activity intends to award a sole source Indefinite Delivery Indefinite Quantity contract to CN Bio Innovations Limited on behalf of the United States Army Medical Research Institute of Infectious Diseases. This Special Notice, posted on April 17, 2026, announces the Government's intention to procure PhysioMimix Organ-on-a-Chip systems and associated consumables and components that are compatible with existing PhysioMimix equipment currently deployed at USAMRIID. The contract will be awarded as a Firm Fixed Price arrangement under the authority of 41 USC 1901. The Government has determined that CN Bio Innovations Limited is the sole source capable of meeting the minimum essential characteristics for this requirement due to proprietary compatibility constraints with existing systems.
The primary objective of this procurement is to obtain specialized organ-on-a-chip technology and compatible consumables to support USAMRIID's research operations. Interested vendors who believe they can provide comparable capabilities have until May 5, 2026, to submit a capability statement with detailed evidence demonstrating their ability to supply transwell-based organoid models compatible with the existing CN Bio PhysioMimix systems. Submissions must provide convincing technical evidence rather than general inquiries to be considered as affirmative challenges to the sole source determination. The Government retains sole discretion in deciding whether to compete this contract based on any responses received. While this notice is not a formal request for quotations and no solicitation document currently exists, vendors may contest the basis for sole sourcing through substantive capability demonstrations that address the compatibility and technical requirements specified.
Notice text
The Defense Health Agency Contracting Activity (DHACA) intends to award a Firm Fixed Price, sole source Indefinite Delivery Indefinite Quantity (IDIQ) contract, on behalf of the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), to CN Bio Innovations Limited, under the authority of 41 USC 1901, as implemented in Revolutionary FAR Overhaul (RFO) 12.102 -- Restricting competition and RFO 12.201-1 – Simplified procedures.
This requirement is for the delivery of PhysioMimix Organ-on-a-Chip systems and associated consumables/components compatible with the existing PhysioMimix systems currently in place at USAMRIID. While similar equipment and consumables may be available from other vendors, the other PhysioMimix systems in the market require the use of proprietary consumables that are not compatible with other transwell based organoid models including the CN Bio PhysioMimix systems currently in use at USAMRIID. CN Bio Innovations Limited is the only vendor capable of providing transwell based organoid models meeting the Government’s minimum essential characteristics and being compatible with the existing CN Bio PhysioMimix systems in use at USAMRIID.
This notice of intent is NOT a request for quotations (RFQ) and no solicitation document exists for the requirement; however, if a vendor challenges the basis for this requirement, please submit a capability statement that includes sufficient detail and with convincing evidence that clearly demonstrates the capability to provide these supplies. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the government not to compete based on responses to this notice is solely within the discretion of the government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source procurement.
Capability statements are due no later than 1000 Eastern Time, 05 May 2026. Capability statements shall be submitted via email ONLY as a Microsoft Word or Adobe PDF attachment to the following email addresses: grant.a.gratton.civ@health.mil and jayme.l.fletcher2.civ@health.mil. No phone calls will be accepted.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| NOTICE OF INTENT TO SOLE SOURCE for the Development of a Handheld Device for Rapid Assessment of Burn Sepsis Risk | — | No set-aside | |
| Notice of Intent to Sole Source – Boston Scientific | NIH Clinical Center | No set-aside | |
| Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. | Medical Command | No set-aside | |
| Notice of Intent DNA Synthesizer | — | No set-aside | |
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity